The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 26, 2021

Filed:

Oct. 02, 2020
Applicant:

Beta Bionics, Inc., Concord, MA (US);

Inventors:

Firas H. El-Khatib, Allston, MA (US);

Edward R. Damiano, Acton, MA (US);

Edward B. Raskin, Irvine, CA (US);

David Chi-Wai Lim, Irvine, CA (US);

Michael J. Rosinko, Anaheim, CA (US);

John R. Costik, Livonia, NY (US);

Assignee:

Beta Bionics, Inc., Concord, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/172 (2006.01); A61M 5/142 (2006.01); G16H 20/17 (2018.01); G16H 40/40 (2018.01); G06F 8/656 (2018.01); H04W 76/10 (2018.01); G06F 8/61 (2018.01); H04L 29/08 (2006.01); G16H 40/60 (2018.01); G16H 80/00 (2018.01); A61M 5/168 (2006.01); G08B 21/04 (2006.01); G08B 21/18 (2006.01); G16H 40/67 (2018.01); G06F 21/30 (2013.01); G06F 21/31 (2013.01); G06F 21/62 (2013.01); G06F 21/84 (2013.01); G16H 10/60 (2018.01); G16H 50/30 (2018.01); G06F 3/0488 (2013.01); G06F 8/65 (2018.01); H04L 29/06 (2006.01); H04W 76/14 (2018.01); H04L 9/08 (2006.01); H04L 9/30 (2006.01); G06F 3/0484 (2013.01); G08B 25/00 (2006.01); A61B 5/145 (2006.01); G16H 40/00 (2018.01);
U.S. Cl.
CPC ...
A61M 5/172 (2013.01); A61M 5/142 (2013.01); A61M 5/14244 (2013.01); A61M 5/14248 (2013.01); A61M 5/16831 (2013.01); G06F 3/04847 (2013.01); G06F 3/04883 (2013.01); G06F 8/61 (2013.01); G06F 8/65 (2013.01); G06F 8/656 (2018.02); G06F 21/305 (2013.01); G06F 21/31 (2013.01); G06F 21/6245 (2013.01); G06F 21/84 (2013.01); G08B 21/0453 (2013.01); G08B 21/18 (2013.01); G16H 10/60 (2018.01); G16H 20/17 (2018.01); G16H 40/40 (2018.01); G16H 40/60 (2018.01); G16H 40/67 (2018.01); G16H 50/30 (2018.01); G16H 80/00 (2018.01); H04L 9/088 (2013.01); H04L 9/30 (2013.01); H04L 63/101 (2013.01); H04L 67/34 (2013.01); H04W 76/10 (2018.02); H04W 76/14 (2018.02); A61B 5/14532 (2013.01); A61M 5/1723 (2013.01); A61M 2005/14208 (2013.01); A61M 2005/1726 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3327 (2013.01); A61M 2205/3546 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/3592 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/505 (2013.01); A61M 2205/52 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01); A61M 2205/609 (2013.01); A61M 2230/201 (2013.01); G08B 25/00 (2013.01); G16H 40/00 (2018.01);
Abstract

An automated blood glucose control system can provide automatic delivery of glucose control therapy to a subject and receive information about manual glucose control therapy provided to the subject. The automated blood glucose control system can indicate an amount of a bolus of medicament via a control algorithm configured to control blood glucose level in the subject. The automated blood glucose control system can indicate an amount of a manual bolus of medicament, which can be used to model a diminishment of the medicament in the subject over time based at least in part on the manual bolus of medicament.


Find Patent Forward Citations

Loading…